Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Psychiatry Res

Retrieve available abstracts of 226 articles:
HTML format

Single Articles

    November 2021
  1. FERNANDEZ DK, Deane FP, Vella SA
    Effects of online continuum and categorical belief manipulations on schizophrenia stigma, help-seeking, and help-provision.
    Psychiatry Res. 2021;307:114293.
    PubMed     Abstract available

  2. GOU N, Xiang Y, Zhou J, Zhang S, et al
    Identification of violent patients with schizophrenia using a hybrid machine learning approach at the individual level.
    Psychiatry Res. 2021;306:114294.
    PubMed     Abstract available

  3. BARR SM, Roberts D, Thakkar KN
    Psychosis in transgender and gender non-conforming individuals: A review of the literature and a call for more research.
    Psychiatry Res. 2021;306:114272.
    PubMed     Abstract available

  4. LYU J, Zhang J
    Suicide means, timing, intent and behavior characteristics of the suicides with schizophrenia.
    Psychiatry Res. 2021;306:114267.
    PubMed     Abstract available

  5. RUSSO M, Consoli S, De Rosa MA, Calisi D, et al
    A case of Sars-Cov-2-related mania with prominent psychosis>.
    Psychiatry Res. 2021;306:114266.

  6. GALLOS IK, Mantonakis L, Spilioti E, Kattoulas E, et al
    The relation of integrated psychological therapy to resting state functional brain connectivity networks in patients with schizophrenia.
    Psychiatry Res. 2021;306:114270.
    PubMed     Abstract available

  7. SANTOS MJ, Ferreira TF, Sequeira M, Trancas B, et al
    Chronic hallucinatory psychosis presenting with olfactory hallucinations: A case report.
    Psychiatry Res. 2021;305:114262.

    October 2021
  8. MENON V, Suhas S, Sethi MIS, Varadharajan N, et al
    Comments on the paper published by Lyu et al on Risk Factors for Suicide in People with Schizophrenia.
    Psychiatry Res. 2021;306:114255.

  9. DAMIANO RF, Avrichir BS, Melzer-Ribeiro DL, Sallet PC, et al
    Which are the best evidence-based therapeutic options for clozapine and ECT resistant schizophrenia? A case-report.
    Psychiatry Res. 2021;305:114248.
    PubMed     Abstract available

  10. PAWELCZYK A, Lojek E, Radek M, Pawelczyk T, et al
    Prosodic deficits and interpersonal difficulties in patients with schizophrenia.
    Psychiatry Res. 2021;306:114244.
    PubMed     Abstract available

  11. LUO X, Zhang L, Zhang J, Chen H, et al
    Changes in the cognitive function of Chinese college students with a clinical high risk of psychosis.
    Psychiatry Res. 2021;305:114242.
    PubMed     Abstract available

  12. CLAYSON PE, Molina JL, Joshi YB, Thomas ML, et al
    Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.
    Psychiatry Res. 2021;305:114239.
    PubMed     Abstract available

  13. JIANG W, Rootes-Murdy K, Chen J, Bizzozero NIP, et al
    Multivariate alterations in insula - Medial prefrontal cortex linked to genetics in 12q24 in schizophrenia.
    Psychiatry Res. 2021;306:114237.
    PubMed     Abstract available

  14. SANCHEZ MC, Escurriola MF, Sanmartin MIF, Solntseva I, et al
    Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care.
    Psychiatry Res. 2021;306:114233.
    PubMed     Abstract available

  15. BRYCE S, Zbukvic I, Wood SJ, Allott K, et al
    Cognitive remediation to address impairment in schizophrenia: Moving beyond effectiveness and toward implementation.
    Psychiatry Res. 2021;305:114232.

  16. MINICHINO A, Singh F, Pineda J, Friederich E, et al
    Corrigendum to 'Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD)' [Psychiatry Research 238 (2016) 374-377].
    Psychiatry Res. 2021;306:114177.

  17. SARZYNSKA-WAWER J, Wawer A, Pawlak A, Szymanowska J, et al
    Detecting formal thought disorder by deep contextualized word representations.
    Psychiatry Res. 2021;304:114135.
    PubMed     Abstract available

    September 2021
  18. LUDTKE T, Ruegg N, Moritz S, Berger T, et al
    Insight and the number of completed modules predict a reduction of positive symptoms in an Internet-based intervention for people with psychosis.
    Psychiatry Res. 2021;306:114223.
    PubMed     Abstract available

  19. ZOU DS, Cowan HR, Azis M, Mittal VA, et al
    Reciprocal Social Behavior and Related Social Outcomes in Individuals at Clinical High Risk for Psychosis.
    Psychiatry Res. 2021;306:114224.
    PubMed     Abstract available

  20. SRIVASTAVA A, Dada O, Qian J, Al-Chalabi N, et al
    Epigenetics of Schizophrenia.
    Psychiatry Res. 2021;305:114218.
    PubMed     Abstract available

  21. FERNANDO R, Gan L, Xiao J, Yun Y, et al
    Hyperprolactinemia induced by brexpiprazole in patients with schizophrenia: A case report.
    Psychiatry Res. 2021;305:114215.

  22. HOMMAN LE, Smart SE, O'Neill F, MacCabe JH, et al
    Attrition in longitudinal studies among patients with schizophrenia and other psychoses; findings from the STRATA collaboration.
    Psychiatry Res. 2021;305:114211.
    PubMed     Abstract available

  23. MISHRA A, Soni AB, Umate MS, Andrade C, et al
    An exploratory evaluation of predictors of duration of untreated psychosis in first-episode psychosis in lower income patients.
    Psychiatry Res. 2021;305:114203.
    PubMed     Abstract available

  24. ZHU L, Zhang W, Zhu Y, Mu X, et al
    Cerebellar theta burst stimulation for the treatment of negative symptoms of schizophrenia: A multicenter, double-blind, randomized controlled trial.
    Psychiatry Res. 2021;305:114204.
    PubMed     Abstract available

  25. SHOSHINA II, Hovis JK, Felisberti FM, Santos NA, et al
    Visual processing and BDNF levels in first-episode schizophrenia.
    Psychiatry Res. 2021;305:114200.
    PubMed     Abstract available

  26. RABINOWITZ J, Rabinowitz AA
    Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Psychiatry Res. 2021;303:114114.
    PubMed     Abstract available

  27. VALERIO KE, Jonas KG, Perlman G, Bromet EJ, et al
    A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.
    Psychiatry Res. 2021;303:114111.
    PubMed     Abstract available

    August 2021
  28. KARTALCI S, Erbay MF, Kahraman A, Candir F, et al
    Evaluation of CSF flow dynamics in patients with schizophrenia using phase-contrast cine MRI.
    Psychiatry Res. 2021;304:114172.
    PubMed     Abstract available

  29. REINFELD S, Caceda R, Gil R, Strom H, et al
    Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report.
    Psychiatry Res. 2021;304:114165.

  30. LYU J, Zhang J, Hennessy DA
    Characteristics and Risk Factors for Suicide in People with Schizophrenia in Comparison to Those without Schizophrenia.
    Psychiatry Res. 2021;304:114166.
    PubMed     Abstract available

  31. YANG H, Xiao W, Yang M, Wang Y, et al
    Decreased neuregulin1beta1 in first episode and drug-naive patients with schizophrenia: Negative correlation with cognitive impairment.
    Psychiatry Res. 2021;304:114164.
    PubMed     Abstract available

  32. SAHIN D, Hever F, Bossert M, Herwig K, et al
    Early and middle latency auditory event-related potentials do not explain differences in neuropsychological performance between schizophrenia spectrum patients and matched healthy controls.
    Psychiatry Res. 2021;304:114162.
    PubMed     Abstract available

  33. DAURE C, Fortias M, Icick R, Delage C, et al
    Oral long acting antipsychotic penfluridol as a harm reduction treatment in a patient suffering from untreated schizophrenia and multiple drug dependence: A case report.
    Psychiatry Res. 2021;304:114147.
    PubMed     Abstract available

    July 2021
  34. DA MOTTA C, Pato MT, Barreto Carvalho C, Castilho P, et al
    The neurocognitive and functional profile of schizophrenia in a genetically homogenous European sample.
    Psychiatry Res. 2021;304:114140.
    PubMed     Abstract available

  35. VOPPEL AE, de Boer JN, Brederoo SG, Schnack HG, et al
    Quantified language connectedness in schizophrenia-spectrum disorders.
    Psychiatry Res. 2021;304:114130.
    PubMed     Abstract available

  36. BOSNJAK KUHARIC D, Makaric P, Kekin I, Rossini Gajsak L, et al
    Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
    Psychiatry Res. 2021;304:114131.
    PubMed     Abstract available

  37. GRACIA DFK, Gomes EMP, Coelho TA, Carriello M, et al
    Ficolin activation as a potential biomarker of the severity of schizophrenia.
    Psychiatry Res. 2021;304:114122.
    PubMed     Abstract available

  38. KU BS, Pauselli L, Covington MA, Compton MT, et al
    Computational linguistic analysis applied to a semantic fluency task: A replication among first-episode psychosis patients with and without derailment and tangentiality.
    Psychiatry Res. 2021;304:114105.
    PubMed     Abstract available

  39. SNELLEKSZ M, Dean B
    Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder.
    Psychiatry Res. 2021;303:114096.
    PubMed     Abstract available

  40. VASKINN A, Engelstad KN, Torgalsboen AK, Rund BR, et al
    Childhood trauma, social cognition and schizophrenia: Specific association between physical neglect and cognitive theory of mind in homicide offenders.
    Psychiatry Res. 2021;303:114093.
    PubMed     Abstract available

  41. JAGADHEESAN K, Danivas V, Itrat Q, Shekaran L, et al
    A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown.
    Psychiatry Res. 2021;303:114081.
    PubMed     Abstract available

    June 2021
  42. CORBERA S, Wexler BE, Bell MD, Pearlson G, et al
    Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.
    Psychiatry Res. 2021;303:114087.
    PubMed     Abstract available

  43. LI S, DeLisi LE, McDonough SI
    Rare germline variants in individuals diagnosed with schizophrenia within multiplex families.
    Psychiatry Res. 2021;303:114038.
    PubMed     Abstract available

  44. CASADO-ORTEGA A, Vila-Badia R, Butjosa A, Del Cacho N, et al
    Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis.
    Psychiatry Res. 2021;302:114040.
    PubMed     Abstract available

  45. ANDREOU D, Jorgensen KN, Wortinger LA, Engen K, et al
    Cytomegalovirus infection and IQ in patients with severe mental illness and healthy individuals.
    Psychiatry Res. 2021;300:113929.
    PubMed     Abstract available

  46. BRAUN D, Schlossmann J, Haen E
    Asymmetric dimethylarginine in psychiatric disorders.
    Psychiatry Res. 2021;300:113901.
    PubMed     Abstract available

    May 2021
  47. KELLY DL, Claxton A, Bidollari I, Du Y, et al
    Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
    Psychiatry Res. 2021;302:114030.
    PubMed     Abstract available

  48. GUILLAUME F, Thomas E
    Recollection and familiarity in schizophrenia:An ERP investigation using face recognition exclusion tasks.
    Psychiatry Res. 2021;302:113973.
    PubMed     Abstract available

  49. SCHEFFLER F, Phahladira L, Luckhoff H, du Plessis S, et al
    Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
    Psychiatry Res. 2021;302:114022.
    PubMed     Abstract available

  50. MUNOZ-SAMONS D, Tor J, Rodriguez-Pascual M, Alvarez-Subiela X, et al
    Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis.
    Psychiatry Res. 2021;303:114017.
    PubMed     Abstract available

  51. HELLER C, Weiss T, Del Re EC, Swago S, et al
    Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.
    Psychiatry Res. 2021;301:113979.
    PubMed     Abstract available

  52. ABEL DB, Salyers MP, Wu W, Monette MA, et al
    Quality versus quantity: Determining real-world social functioning deficits in schizophrenia.
    Psychiatry Res. 2021;301:113980.
    PubMed     Abstract available

    April 2021
  53. ALBA L, Coll C, Saez S, Alonso L, et al
    New-onset psychosis: A case report of brief psychosis related to COVID-19 infection.
    Psychiatry Res. 2021;301:113975.

  54. UCOK A, Karakas B, Sahin OS
    Formal thought disorder in patients with first-episode schizophrenia: Results of a one-year follow-up study.
    Psychiatry Res. 2021;301:113972.
    PubMed     Abstract available

  55. Discrepancies between staff and gold standard ratings of schizophrenia symptom severity.
    Psychiatry Res. 2021;301:113963.

  56. DE PERI L, Deste G, Vita A
    Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed.
    Psychiatry Res. 2021;301:113962.
    PubMed     Abstract available

  57. MEDALIA A, Saperstein AM, Stefancic A, Meyler S, et al
    Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.
    Psychiatry Res. 2021;301:113956.
    PubMed     Abstract available

  58. XIE YJ, Xi YB, Cui LB, Guan MZ, et al
    Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia.
    Psychiatry Res. 2021;300:113937.
    PubMed     Abstract available

  59. PENNOU A, Lecomte T, Khazaal Y, Potvin S, et al
    Does theory of mind predict specific domains of social functioning in individuals following a first episode psychosis?
    Psychiatry Res. 2021;301:113933.
    PubMed     Abstract available

  60. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Sequencing of the coding regions of GNBIL on chromosome 22q11.2 as a risk gene of schizophrenia.
    Psychiatry Res. 2021;300:113943.
    PubMed     Abstract available

  61. SCHURHOFF F, Corfdir C, Pignon B, Lajnef M, et al
    No alteration of leukocyte telomere length in first episode psychosis.
    Psychiatry Res. 2021;301:113941.
    PubMed     Abstract available

  62. VAERNES TG, Rossberg JI, Melle I, Nelson B, et al
    Basic self-disturbance in subjects at clinical high risk for psychosis: Relationship with clinical and functional outcomes at one year follow-up.
    Psychiatry Res. 2021;300:113942.
    PubMed     Abstract available

  63. STRASSNIG MT, Miller ML, Moore R, Depp CA, et al
    Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.
    Psychiatry Res. 2021;300:113924.
    PubMed     Abstract available

  64. SIDDIQUI SV, Nizamie SH, Siddiqui MA, Jahan M, et al
    Evaluation of N-400 Evoked Response Potential in schizophrenia: An endophenotype or a disease marker?
    Psychiatry Res. 2021;300:113907.
    PubMed     Abstract available

    March 2021
  65. AU RWC, Sezto HNW, Lam VWM, Wan YT, et al
    Brief report: A randomized controlled trial of a compensatory cognitive training to improve prospective memory performance in people with schizophrenia or depression.
    Psychiatry Res. 2021;300:113914.
    PubMed     Abstract available

  66. LI M, Liu Y, Qiu Y, Zhang J, et al
    The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
    Psychiatry Res. 2021;300:113899.
    PubMed     Abstract available

  67. GAN H, Zhu J, Zhuo K, Zhang J, et al
    High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial.
    Psychiatry Res. 2021;299:113876.
    PubMed     Abstract available

  68. PAN Z, Xiong D, Xiao H, Li J, et al
    The Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Chronic Schizophrenia: Insights from EEG Microstates.
    Psychiatry Res. 2021;299:113866.
    PubMed     Abstract available

  69. LUCKHOFF HK, Asmal L, Scheffler F, du Plessis S, et al
    Gender role endorsement in first-episode schizophrenia spectrum disorders.
    Psychiatry Res. 2021;299:113867.
    PubMed     Abstract available

  70. YANG F, Ma H, Yuan J, Wei Y, et al
    Correlation of abnormalities in resting state fMRI with executive functioning in chronic schizophrenia.
    Psychiatry Res. 2021;299:113862.
    PubMed     Abstract available

  71. BERTRAND T, Tavitian A, Galindez JM, Kothari V, et al
    Heme oxygenase-1 in blood and saliva during acute psychosis: A pilot study.
    Psychiatry Res. 2021;299:113857.
    PubMed     Abstract available

  72. PARK HJ, Kang WS, Kim JW
    Association between the promoter haplotype of RTN4 gene and schizophrenia in a Korean population.
    Psychiatry Res. 2021;299:113841.
    PubMed     Abstract available

  73. BIAN Y, Lin C, Ma B, Han X, et al
    Effect of subjective sleep quality on learning and memory in drug-free patients with schizophrenia.
    Psychiatry Res. 2021;299:113849.
    PubMed     Abstract available

  74. CANTY AL, Cao Y, Neumann D, Shum DHK, et al
    The functional significance of cognitive empathy and theory of mind in early and chronic schizophrenia.
    Psychiatry Res. 2021;299:113852.
    PubMed     Abstract available

  75. SIMON AE, Keller P, Cattapan K
    Commentary about social avoidance and its significance in adolescents and young adults.
    Psychiatry Res. 2021;297:113718.
    PubMed     Abstract available

  76. TOYODA K, Hata T, Yamauchi S, Kinoshita S, et al
    A descriptive study of 10-year clozapine use from the nationwide database in Japan.
    Psychiatry Res. 2021;297:113764.
    PubMed     Abstract available

  77. O'CONNOR C, Vaughan S
    Does selectively endorsing different approaches to treating mental illness affect lay beliefs about the cause and course of mental illness?
    Psychiatry Res. 2021;297:113726.
    PubMed     Abstract available

    February 2021
  78. CRUZ BF, de Campos-Carli SM, de Oliveira AM, de Brito CB, et al
    Investigating potential associations between neurocognition/social cognition and oxidative stress in schizophrenia.
    Psychiatry Res. 2021;298:113832.
    PubMed     Abstract available

  79. GOGOS A, Sun J, Udawela M, Gibbons A, et al
    Cortical expression of the RAPGEF1 gene in schizophrenia: investigating regional differences and suicide.
    Psychiatry Res. 2021;298:113818.
    PubMed     Abstract available

  80. BELVEDERI MURRI M, Zotos S, Cantarelli L, Berardi L, et al
    Between China and Italy: A case report of first-episode schizophrenia in the Covid-19 era.
    Psychiatry Res. 2021;298:113804.

  81. ESPOSITO CM, D'Agostino A, Dell Osso B, Fiorentini A, et al
    Impact of the first Covid-19 pandemic wave on first episode psychosis in Milan, italy.
    Psychiatry Res. 2021;298:113802.
    PubMed     Abstract available

  82. BJORKLY S, Laake P, Roaldset JO, Douglas KS, et al
    The Safe pilot study: A prospective naturalistic study with repeated measures design to test the psychosis - violence link in and after discharge from forensic facilities.
    Psychiatry Res. 2021;298:113793.
    PubMed     Abstract available

  83. RENDON-QUINTERO E, Ortiz K, Vallejo Silva A
    SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA.
    Psychiatry Res. 2021;298:113785.
    PubMed     Abstract available

  84. BERNARDIN F, Schwitzer T, Angioi-Duprez K, Giersch A, et al
    Retinal ganglion cell dysfunction is correlated with disturbed visual cognition in schizophrenia patients with visual hallucinations.
    Psychiatry Res. 2021;298:113780.
    PubMed     Abstract available

  85. SREERAJ VS, Holla B, Ithal D, Nadella RK, et al
    Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study.
    Psychiatry Res. 2021;296:113647.
    PubMed     Abstract available

  86. MORRIS E, Batallones R, Ryan J, Slomp C, et al
    Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Psychiatry Res. 2021;296:113663.
    PubMed     Abstract available

  87. CAMUS D, Dan Glauser ES, Gholamrezaee M, Gasser J, et al
    Factors associated with repetitive violent behavior of psychiatric inpatients.
    Psychiatry Res. 2021;296:113643.
    PubMed     Abstract available

  88. GURCAN G, Senol SH, Yagcioglu AEA, Ertugrul A, et al
    Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.
    Psychiatry Res. 2021;296:113665.
    PubMed     Abstract available

  89. KHARE C, Mueser KT, Bahaley M, Vax S, et al
    Employment in people with severe mental illnesses receiving public sector psychiatric services in India.
    Psychiatry Res. 2021;296:113673.
    PubMed     Abstract available

    January 2021
  90. PHAHLADIRA L, Asmal L, Luckhoff HK, du Plessis S, et al
    The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal study.
    Psychiatry Res. 2021;298:113767.
    PubMed     Abstract available

  91. GOSEK P, Kotowska J, Rowinska-Garbien E, Bartczak D, et al
    Treatment resistance and prolonged length of stay among schizophrenia inpatients in forensic institutions.
    Psychiatry Res. 2021;298:113771.
    PubMed     Abstract available

  92. TRONCHIN G, McPhilemy G, Ahmed M, Kilmartin L, et al
    White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study.
    Psychiatry Res. 2021;298:113772.
    PubMed     Abstract available

  93. KLAUS F, Guetter K, Schlegel R, Seifritz E, et al
    Peripheral biopterin and neopterin in schizophrenia and depression.
    Psychiatry Res. 2021;297:113745.
    PubMed     Abstract available

  94. MOTA P
    "I have no disease and weed just relaxes me!": The therapeutic challenge in young patients with psychosis and cannabis abuse.
    Psychiatry Res. 2021;297:113741.

  95. LUCA P, Rafael T, Emilio B, Antonio V, et al
    Are Schizophrenic disorders with or without early cannabis use neurobiologically distinct disease entities? A meta-analysis of magnetic resonance imaging studies.
    Psychiatry Res. 2021;297:113731.
    PubMed     Abstract available

  96. ZAHID A, Best MW
    Stigma towards individuals with schizophrenia: Examining the effects of negative symptoms and diagnosis awareness on preference for social distance.
    Psychiatry Res. 2021;297:113724.
    PubMed     Abstract available

  97. CHEN D, Li H, Zhao Q, Song J, et al
    Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naive first-episode schizophrenia.
    Psychiatry Res. 2021;297:113717.
    PubMed     Abstract available

  98. FATTAHI C, Hamada K, Chiang M, Kosuru S, et al
    A narrative review of mindfulness-based therapy for schizophrenia, co-occurring substance use and comorbid cardiometabolic problems.
    Psychiatry Res. 2021;296:113707.
    PubMed     Abstract available

  99. SERRA-MAYORAL A, Mareca C, Cano R, Romaguera A, et al
    The BAT: A videotaped battery to assess theory of mind in schizophrenia.
    Psychiatry Res. 2021;297:113709.
    PubMed     Abstract available

  100. SELVARAJ S, Chhabra H, Dinakaran D, Sreeraj VS, et al
    Auditory signal detection in schizophrenia: Correlates with auditory verbal hallucinations & effect of single session transcranial direct current stimulation (tDCS).
    Psychiatry Res. 2021;297:113704.
    PubMed     Abstract available

  101. SEILER N, Hunter J, Waterdrinker A, Das S, et al
    Psychopathological consequences of the COVID-19 pandemic: A case report of psychosis.
    Psychiatry Res. 2021;296:113703.

  102. KETHARANATHAN T, Pereira A, Reets U, Walker D, et al
    Brain changes in NF-kappaB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation.
    Psychiatry Res. 2021;295:113564.
    PubMed     Abstract available

    December 2020
  103. MARTINI F, Spangaro M, Buonocore M, Bechi M, et al
    Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex.
    Psychiatry Res. 2020;297:113698.
    PubMed     Abstract available

  104. ROSEBROCK LE, Waite F, Diamond R, Collett N, et al
    Anticipatory pleasure in current psychosis: Cognitive and emotional correlates.
    Psychiatry Res. 2020;297:113697.
    PubMed     Abstract available

  105. MAAGENSEN H, Larsen JR, Jorgensen NR, Fink-Jensen A, et al
    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes - randomized controlled trial.
    Psychiatry Res. 2020;296:113670.
    PubMed     Abstract available

  106. LIU Y, Gu N, Cao X, Zhu Y, et al
    Effects of transcranial electrical stimulation on working memory in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;296:113656.
    PubMed     Abstract available

  107. DADA O, Adanty C, Dai N, Jeremian R, et al
    Biological aging in schizophrenia and psychosis severity: DNA methylation analysis.
    Psychiatry Res. 2020;296:113646.
    PubMed     Abstract available

  108. NG QX, Chong JWX, Yong CSK, Sivalingam V, et al
    Re-considering the use of bupropion in schizophrenia: A case report and review of literature.
    Psychiatry Res. 2020;295:113636.

  109. SURMANN M, Falke S, von Gruchalla L, Maisch B, et al
    Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis.
    Psychiatry Res. 2020;295:113601.
    PubMed     Abstract available

  110. MAHMOOD Z, Van Patten R, Keller AV, Lykins HC, et al
    Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention.
    Psychiatry Res. 2020;295:113620.
    PubMed     Abstract available

    November 2020
  111. STEFANOVA M, Taylor G, Jacobsen P
    Who gets evidence-based therapy for psychosis following a psychiatric hospital admission? Follow-up data from an inpatient randomised controlled trial.
    Psychiatry Res. 2020;295:113605.
    PubMed     Abstract available

  112. THOMAS M, Szentgyorgyi T, Vanes LD, Mouchlianitis E, et al
    Cognitive performance in early, treatment-resistant psychosis patients: Could cognitive control play a role in persistent symptoms?
    Psychiatry Res. 2020;295:113607.
    PubMed     Abstract available

  113. TOUS-ESPELOSIN M, de Azua SR, Iriarte-Yoller N, MartinezAguirre-Betolaza A, et al
    Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia.
    Psychiatry Res. 2020 Nov 18:113580. doi: 10.1016/j.psychres.2020.113580.
    PubMed     Abstract available

  114. PENG Y, Zhang S, Zhou Y, Song Y, et al
    Abnormal functional connectivity based on nodes of the default mode network in first-episode drug-naive early-onset schizophrenia.
    Psychiatry Res. 2020 Nov 18:113578. doi: 10.1016/j.psychres.2020.113578.
    PubMed     Abstract available

  115. DELISI LE
    A commentary revisiting the viral hypothesis of schizophrenia: Onset of a schizophreniform disorder subsequent to SARS CoV-2 infection.
    Psychiatry Res. 2020 Nov 16:113573. doi: 10.1016/j.psychres.2020.113573.
    PubMed     Abstract available

  116. HOPKINS SC, Ogirala A, Loebel A, Koblan KS, et al
    Characterization of specific and distinct patient types in clinical trials of acute schizophrenia using an uncorrelated PANSS score matrix transform (UPSM).
    Psychiatry Res. 2020 Nov 11:113569. doi: 10.1016/j.psychres.2020.113569.
    PubMed     Abstract available

  117. PALOMAR-CIRIA N, Alonso-Alvarez D, Vazquez-Beltran P, Blanco Del Valle P, et al
    Commentary to "Schizophrenia and COVID-19 Delirium", an update.
    Psychiatry Res. 2020;294:113555.

  118. GUIDARA W, Messedi M, Naifar M, Maalej M, et al
    Predictive value of oxidative stress biomarkers in drugfree patients with schizophrenia and schizo-affective disorder.
    Psychiatry Res. 2020;293:113467.
    PubMed     Abstract available

  119. LOU S, Xue X
    Application of electroencephalographic (EEG) biofeedback therapy in the rehabilitation of patients with chronic diseases.
    Psychiatry Res. 2020;293:113371.
    PubMed     Abstract available

    October 2020
  120. PELIZZA L, Maestri D, Leuci E, Quattrone E, et al
    Negative symptom configuration within and outside schizophrenia spectrum disorders: results from the "Parma Early Psychosis" program.
    Psychiatry Res. 2020;294:113519.
    PubMed     Abstract available

  121. GRIMES KM DR, Foussias G, Remington G, Kalahani-Bargis K, et al
    Stability of Verbal Fluency in Outpatients with Schizophrenia.
    Psychiatry Res. 2020 Oct 23:113528. doi: 10.1016/j.psychres.2020.113528.
    PubMed     Abstract available

  122. GRATTAN RE, Tryon VL, Carter CS, Niendam TA, et al
    Suicide behavior is associated with childhood emotion dysregulation but not trait impulsivity in first episode psychosis.
    Psychiatry Res. 2020;294:113517.
    PubMed     Abstract available

  123. AJNAKINA O, Agbedjro D, Lally J, Forti MD, et al
    Predicting onset of early- and late-treatment resistance in first-episode schizophrenia patients using advanced shrinkage statistical methods in a small sample.
    Psychiatry Res. 2020;294:113527.
    PubMed     Abstract available

  124. SIMOILA L, Isometsa E, Gissler M, Suvisaari J, et al
    Pregnancy, delivery and postpartum in women with schizophrenia or schizoaffective disorder in Finland: a national register-based comparative study.
    Psychiatry Res. 2020;294:113504.
    PubMed     Abstract available

  125. SCOTT M, Rossell SL, Toh WL, Thomas N, et al
    The relationship between anxiety, depression, and subtypes of negative auditory verbal hallucination (AVH) content in affective and non-affective psychosis.
    Psychiatry Res. 2020;294:113500.
    PubMed     Abstract available

  126. MCGOVERN JE, Masucci MD, Le TP, Cohen AS, et al
    The (b)link between amotivation and psychosis: Insights through phasic eye blink rate.
    Psychiatry Res. 2020;294:113490.
    PubMed     Abstract available

  127. RANDERS L, Fagerlund B, Jepsen JRM, Nordholm D, et al
    Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Psychiatry Res. 2020;294:113498.
    PubMed     Abstract available

  128. KELLY DL, Spaderna M, Hodzic V, Nair S, et al
    Blinded Clinical Ratings of Social Media Data are Correlated with In-Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls.
    Psychiatry Res. 2020;294:113496.
    PubMed     Abstract available

  129. TALIERCIO J, Bonasera B, Portillo C, Ramjas E, et al
    Physical Activity, Sleep-related Behaviors and Severity of Symptoms in Schizophrenia.
    Psychiatry Res. 2020;294:113489.
    PubMed     Abstract available

  130. SCHUTTE MJL, Linszen MMJ, Marschall TM, Ffytche DH, et al
    Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features.
    Psychiatry Res. 2020;292:113314.
    PubMed     Abstract available

    September 2020
  131. MA C, Li Y, Li X, Liu J, et al
    Identification of a functional SNP rs7304782 at schizophrenia risk locus 12q24.31 and validation of its association with schiz ophrenia in Chinese populations.
    Psychiatry Res. 2020;294:113491.
    PubMed     Abstract available

  132. YAN P, Song M, Gao B, Wang S, et al
    Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.
    Psychiatry Res. 2020;293:113470.
    PubMed     Abstract available

  133. JIA R, Liang D, Yu J, Lu G, et al
    The effectiveness of adjunct music therapy for patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;293:113464.
    PubMed     Abstract available

  134. CUI Y, Piao Y, Kim SW, Lee BJ, et al
    Psychological factors intervening between childhood trauma and suicidality in first-episode psychosis.
    Psychiatry Res. 2020;293:113465.
    PubMed     Abstract available

  135. CAO B, Chen Y, McIntyre RS, Yan L, et al
    Acyl-Carnitine plasma levels and their association with metabolic syndrome in individuals with schizophrenia.
    Psychiatry Res. 2020;293:113458.
    PubMed     Abstract available

  136. BEN AFIA A, Aflouk Y, Saoud H, Zaafrane F, et al
    Inteurleukin-8 gene variations and the susceptibility to schizophrenia.
    Psychiatry Res. 2020;293:113421.
    PubMed     Abstract available

  137. HATANO M, Kamei H, Shimato A, Yamada S, et al
    Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database.
    Psychiatry Res. 2020;291:113249.
    PubMed     Abstract available

  138. KATINA S, Kelly BD, Rojas MA, Sukno FM, et al
    Refining the resolution of craniofacial dysmorphology in bipolar disorder as an index of brain dysmorphogenesis.
    Psychiatry Res. 2020;291:113243.
    PubMed     Abstract available

  139. PEREDO R, Gagne AM, Gilbert E, Hebert M, et al
    Electroretinography may reveal cognitive impairment among a cohort of subjects at risk of a major psychiatric disorder.
    Psychiatry Res. 2020;291:113227.
    PubMed     Abstract available

  140. LANGLOIS T, Sanchez-Rodriguez R, Bourcier A, Lamy P, et al
    Impact of the group intervention "Accept Voices(c)" for the management of auditory hallucinations.
    Psychiatry Res. 2020;291:113159.
    PubMed     Abstract available

    August 2020
  141. MELAMED SB, Farfel A, Gur S, Krivoy A, et al
    Thyroid function assessment before and after diagnosis of schizophrenia: A community-based study.
    Psychiatry Res. 2020;293:113356.
    PubMed     Abstract available

  142. ADAMS SW, Yanos PT
    Pathways to aggression and violence in psychosis without longstanding antisocial behavior: A review and proposed psychosocial model for integrative clinical interventions.
    Psychiatry Res. 2020;293:113427.
    PubMed     Abstract available

  143. DE VOS C, Leopold K, Blanke ES, Siebert S, et al
    The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    Psychiatry Res. 2020;293:113424.
    PubMed     Abstract available

  144. SHANNON A, McGuire D, Brown E, O'Donoghue B, et al
    A systematic review of the effectiveness of group-based exercise interventions for individuals with first episode psychosis.
    Psychiatry Res. 2020;293:113402.
    PubMed     Abstract available

  145. CUESTA MJ, Sanchez-Torres AM, Lorente-Omenaca R, Zandio M, et al
    Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Psychiatry Res. 2020;293:113404.
    PubMed     Abstract available

  146. PROKOPEZ CR, Vallejos M, Farinola R, Alberio G, et al
    The history of multiple adverse childhood experiences in patients with schizophrenia is associated with more severe symptomatology and suicidal behavior with gender-specific characteristics.
    Psychiatry Res. 2020;293:113411.
    PubMed     Abstract available

  147. STRASSNIG M, Jones MT, Pinkham A, Penn D, et al
    Depression, hostility, attributional biases, and paranoia in schizophrenia and healthy controls: intercorrelations and associations with self-assessment of social functioning.
    Psychiatry Res. 2020;293:113388.

  148. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Genetic analysis of the NR2E1 gene as a candidate gene of schizophrenia.
    Psychiatry Res. 2020;293:113386.
    PubMed     Abstract available

  149. GIBSON CL, Bassir Nia A, Spriggs SA, DeFrancisco D, et al
    Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.
    Psychiatry Res. 2020;293:113380.
    PubMed     Abstract available

  150. BOKA E, Pozzo JD, Goetz D, Remsen B, et al
    Ineffective risk-reward learning in schizophrenia.
    Psychiatry Res. 2020;293:113370.
    PubMed     Abstract available

  151. WAMBUA GN, Kilian S, Ntlantsana V, Chiliza B, et al
    The association between resilience and psychosocial functioning in schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;293:113374.
    PubMed     Abstract available

  152. LIN X, Deng J, Dong G, Li S, et al
    Effects of Chronic Pharmacological Treatment on Functional Brain Network Connectivity in Patients with Schizophrenia.
    Psychiatry Res. 2020 Aug 4:113338. doi: 10.1016/j.psychres.2020.113338.
    PubMed     Abstract available

  153. GRIGORIOU M, Upthegrove R
    Blunted affect and suicide in schizophrenia: A systematic review.
    Psychiatry Res. 2020;293:113355.
    PubMed     Abstract available

  154. JENSEN RAA, Thomsen DK, Bliksted VF, Ladegaard N, et al
    Narrative Identity in Psychopathology: A Negative Past and a Bright but Foreshortened Future.
    Psychiatry Res. 2020;290:113103.
    PubMed     Abstract available

  155. LALOYAUX J, Collazzoni A, Hirnstein M, Kusztrits I, et al
    Personal resilience factors protect against distressing auditory hallucinations: A study comparing psychotic patients with auditory hallucinations, non-patients with auditory hallucinations, and healthy controls.
    Psychiatry Res. 2020;290:113058.
    PubMed     Abstract available

    July 2020
  156. CULLEN BA, Rodriguez K, Eaton WW, Mojtabai R, et al
    Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.
    Psychiatry Res. 2020;292:113346.
    PubMed     Abstract available

  157. CAQUEO-URIZAR A, Ferrer R, Ponce F, Urzua A, et al
    Clinical outcomes of schizophrenia: A differential study among Latin-American countries.
    Psychiatry Res. 2020;292:113334.

  158. QING L, Liu L, Zhou L, Zhang F, et al
    Sex-dependent association of mineralocorticoid receptor gene (NR3C2) DNA methylation and schizophrenia.
    Psychiatry Res. 2020;292:113318.
    PubMed     Abstract available

  159. PU J, Liu Y, Gui S, Tian L, et al
    Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
    Psychiatry Res. 2020;292:113319.
    PubMed     Abstract available

  160. OHAYON S, Yitzhaky A, Hertzberg L
    Gene expression meta-analysis reveals the up-regulation of CREB1 and CREBBP in Brodmann Area 10 of patients with schizophrenia.
    Psychiatry Res. 2020;292:113311.
    PubMed     Abstract available

  161. HE Q, You Y, Yu L, Yao L, et al
    Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;292:113305.
    PubMed     Abstract available

  162. CEYLAN D, Akdede BB, Bora E, Aktener AY, et al
    Neurocognitive functioning during symptomatic states and remission in bipolar disorder and schizophrenia: A comparative study.
    Psychiatry Res. 2020;292:113292.
    PubMed     Abstract available

  163. KEZAI AM, Lecoeur C, Hot D, Bounechada M, et al
    Association between schizophrenia and Toxoplasma gondii infection in Algeria.
    Psychiatry Res. 2020;291:113293.
    PubMed     Abstract available

  164. FIERINI F, Moretti D, Ballerini A
    Psychosis spectrum disorders during and after the COVID-19 pandemic: Warning signs of "stress incubation".
    Psychiatry Res. 2020;291:113291.

  165. OLUWOYE O, Stokes B, Stiles B, Monroe-DeVita M, et al
    Understanding differences in family engagement and provider outreach in New Journeys: A coordinated specialty care program for first episode psychosis.
    Psychiatry Res. 2020;291:113286.
    PubMed     Abstract available

  166. KOOLA MM, Looney SW, Hong H, Pillai A, et al
    Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement.
    Psychiatry Res. 2020;291:113285.
    PubMed     Abstract available

  167. FORTGANG RG, Hoff RA, Potenza MN
    Schizophrenia symptom severity and motivations for gambling in individuals with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2020;291:113281.
    PubMed     Abstract available

  168. KONJEVOD M, Nikolac Perkovic M, Svob Strac D, Uzun S, et al
    Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence.
    Psychiatry Res. 2020;291:113278.
    PubMed     Abstract available

  169. KERN RS, Reddy LF, Cohen AN, Young AS, et al
    Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia.
    Psychiatry Res. 2020;291:113258.
    PubMed     Abstract available

  170. SUMNER PJ, Carruthers SP, Rossell SL
    Examining Self-Reported Thought Disorder: Continuous Variation, Convergence with Schizotypy, and Cognitive Correlates.
    Psychiatry Res. 2020;289:112943.
    PubMed     Abstract available

    June 2020
  171. PAN R, Zhang X, Gao J, Yi W, et al
    Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study.
    Psychiatry Res. 2020;291:113260.
    PubMed     Abstract available

  172. KOPELLI E, Samara M, Siargkas A, Goulas A, et al
    The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis.
    Psychiatry Res. 2020;291:113246.
    PubMed     Abstract available

  173. DICKERSON F, Schroeder JR, Nimgaonkar V, Gold J, et al
    The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;291:113157.
    PubMed     Abstract available

  174. MOSCHOPOULOS N, Nimatoudis I, Kaprinis S, Sidiras C, et al
    Auditory processing disorder may be present in schizophrenia and it is highly correlated with formal thought disorder.
    Psychiatry Res. 2020;291:113222.
    PubMed     Abstract available

  175. VUKOJEVIC J, Susac J, Brecic P
    Psychosis and pandemics: Is there a secret protector?
    Psychiatry Res. 2020;291:113199.

  176. MENEGHELLI A, Barbera S, Meliante M, Monzani E, et al
    Outcome at 2-year of treatment in first-episode psychosis patients who were enrolled in a specialized early intervention program.
    Psychiatry Res. 2020;291:113200.
    PubMed     Abstract available

  177. HAGEN JM, Sutterland AL, Edrisy S, Tan HL, et al
    Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study.
    Psychiatry Res. 2020;291:113192.
    PubMed     Abstract available

  178. LYSAKER PH, Chernov N, Moiseeva T, Sozinova M, et al
    Contrasting metacognitive profiles and their association with negative symptoms in groups with schizophrenia, early psychosis and depression in a Russian sample.
    Psychiatry Res. 2020;291:113177.
    PubMed     Abstract available

  179. HOLZLE P, Aly L, Frank W, Forstl H, et al
    COVID-19 distresses the depressed while schizophrenic patients are unimpressed: A study on psychiatric inpatients.
    Psychiatry Res. 2020;291:113175.

  180. ZHAND N, Osborne R, Stuyt M, Hatko A, et al
    Incidental finding of age and time disorientation in a clinical sample of patients with schizophrenia: Findings from a short term follow up survey regarding cannabis use.
    Psychiatry Res. 2020;290:113150.
    PubMed     Abstract available

  181. TOH WL, Thomas N, Hollander Y, Rossell SL, et al
    On the phenomenology of auditory verbal hallucinations in affective and non-affective psychosis.
    Psychiatry Res. 2020;290:113147.
    PubMed     Abstract available

  182. MICHAEL GA, Dorey JM, Rey R, D'Amato T, et al
    Attention in schizophrenia: Impaired inhibitory control, faulty attentional resources, or both?
    Psychiatry Res. 2020;290:113164.
    PubMed     Abstract available

  183. COOK JA, Burke-Miller JK, Jonikas JA, Aranda F, et al
    Factors associated with 30-day readmissions following medical hospitalizations among Medicaid beneficiaries with schizophrenia, bipolar disorder, and major depressive disorder.
    Psychiatry Res. 2020;291:113168.
    PubMed     Abstract available

    May 2020
    Commentary on "Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: A case report".
    Psychiatry Res. 2020;290:113144.

  185. MAVROGIORGOU P, Haller K, Juckel G
    Death anxiety and attitude to death in patients with schizophrenia and depression.
    Psychiatry Res. 2020;290:113148.
    PubMed     Abstract available

  186. LI J, Cao X, Liu S, Li X, et al
    Efficacy of repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;290:113141.
    PubMed     Abstract available

  187. KHOBRAGADE B, Sharma V, Deshpande SN
    A study on tobacco use in women with major mental illnesses- schizophrenia, bipolar disorder and recurrent depression.
    Psychiatry Res. 2020;290:113121.
    PubMed     Abstract available

  188. PALOMAR-CIRIA N, Blanco Del Valle P, Hernandez-Las Heras MA, Martinez-Gallardo R, et al
    Schizophrenia and COVID-19 delirium.
    Psychiatry Res. 2020;290:113137.
    PubMed     Abstract available

  189. CHANDRA PS, Shiva L, Nagendrappa S, Ganjekar S, et al
    COVID 19 related Psychosis as an interface of fears, socio-cultural issues and vulnerability- case report of two women from India.
    Psychiatry Res. 2020;290:113136.

  190. VALERY KM, Prouteau A
    Schizophrenia stigma in mental health professionals and associated factors: A systematic review.
    Psychiatry Res. 2020;290:113068.
    PubMed     Abstract available

  191. SREERAJ VS, Suhas S, Parlikar R, Selvaraj S, et al
    Effect of add-on transcranial alternating current stimulation (tACS) on persistent delusions in schizophrenia.
    Psychiatry Res. 2020;290:113106.
    PubMed     Abstract available

  192. SAKANAKA S, Tsujii N, Morimoto H, Shirakawa O, et al
    Aggressiveness is associated with excitement on the five-factor model of the positive and negative syndrome scale and prefrontal function in patients with stable schizophrenia.
    Psychiatry Res. 2020;290:113054.
    PubMed     Abstract available

  193. CORREA-PALACIO AF, Hernandez-Huerta D, Gomez-Arnau J, Loeck C, et al
    Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
    Psychiatry Res. 2020;290:113115.

  194. KANG Y, Huang K, Lin Y, Xu H, et al
    Abnormalities of effective connectivity and white matter microstructure in the triple network in patients with schizophrenia.
    Psychiatry Res. 2020;290:113019.
    PubMed     Abstract available

  195. VEGA-SEVEY JG, Martinez-Magana JJ, Genis-Mendoza AD, Escamilla M, et al
    Copy number variants in siblings of Mexican origin concordant for schizophrenia or bipolar disorder.
    Psychiatry Res. 2020;291:113018.
    PubMed     Abstract available

  196. JOHANSSON M, Hjarthag F, Helldin L
    Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders.
    Psychiatry Res. 2020;289:113035.
    PubMed     Abstract available

  197. SJOLIE C, Meyn EK, Raudeberg R, Andreassen OA, et al
    Nonsocial cognitive underpinnings of theory of mind in schizophrenia.
    Psychiatry Res. 2020;289:113055.
    PubMed     Abstract available

  198. KITOKO GMB, Maurage P, Ma Miezi SM, Gillain B, et al
    Inter-individual variability of social perception and social knowledge impairments among patients with schizophrenia.
    Psychiatry Res. 2020;290:112951.
    PubMed     Abstract available

  199. HERMANS K, van der Steen Y, Kasanova Z, van Winkel R, et al
    Temporal dynamics of suspiciousness and hallucinations in clinical high risk and first episode psychosis.
    Psychiatry Res. 2020;290:113039.
    PubMed     Abstract available

  200. MARTIN DR, Gonzalez AJ, Perez CPL, Sesmero SA, et al
    New-onset psychosis in COVID-19 pandemic: a case series in Madrid.
    Psychiatry Res. 2020 May 13:113097. doi: 10.1016/j.psychres.2020.113097.

  201. RENTERO D, Juanes A, Losada CP, Alvarez S, et al
    New-onset psychosis in COVID-19 pandemic: a case series in Madrid.
    Psychiatry Res. 2020;290:113097.

  202. HUARCAYA-VICTORIA J, Herrera D, Castillo C
    Psychosis in a patient with anxiety related to COVID-19: A case report.
    Psychiatry Res. 2020;289:113052.

  203. HOSSAIN MM, Khan N, Sultana A, Ma P, et al
    Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2020;287:112922.
    PubMed     Abstract available

    April 2020
  204. MASAOKA Y, Velakoulis D, Brewer WJ, Cropley VL, et al
    Impaired olfactory ability associated with larger left hippocampus and rectus volumes at earliest stages of schizophrenia: A sign of neuroinflammation?
    Psychiatry Res. 2020;289:112909.
    PubMed     Abstract available

  205. KILIAN S, Asmal L, Phahladira L, Plessis SD, et al
    The association between childhood trauma and treatment outcomes in schizophrenia spectrum disorders.
    Psychiatry Res. 2020;289:113004.
    PubMed     Abstract available

  206. RANDERS L, Jepsen JRM, Fagerlund B, Nordholm D, et al
    Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Psychiatry Res. 2020;290:112969.
    PubMed     Abstract available

  207. GAINSFORD K, Fitzgibbon B, Fitzgerald PB, Hoy KE, et al
    Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.
    Psychiatry Res. 2020;288:112974.
    PubMed     Abstract available

  208. ZHU JL, Luo WW, Cheng X, Li Y, et al
    Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies.
    Psychiatry Res. 2020;288:112959.
    PubMed     Abstract available

  209. BAANDRUP L, Allerup P, Nielsen MO, Bak N, et al
    Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
    Psychiatry Res. 2020;289:112970.
    PubMed     Abstract available

  210. FISCHER M, Coogan AN, Faltraco F, Thome J, et al
    COVID-19 paranoia in a patient suffering from schizophrenic psychosis - a case report.
    Psychiatry Res. 2020;288:113001.

  211. VIDARSDOTTIR OG, Twamley EW, Roberts DL, Sigurdsson E, et al
    Integrative cognitive remediation for early psychosis: A 12-month follow-up.
    Psychiatry Res. 2020;288:112964.
    PubMed     Abstract available

  212. ADHAN I, Lizano P, Bannai D, Lutz O, et al
    Visual Cortical Alterations and their Association with Negative Symptoms in Antipsychotic-Naive First Episode Psychosis.
    Psychiatry Res. 2020;288:112957.
    PubMed     Abstract available

  213. CHEN S, Xia X, Deng C, Wu X, et al
    The correlation between metabolic syndrome and neurocognitive and social cognitive performance of patients with schizophrenia.
    Psychiatry Res. 2020;288:112941.
    PubMed     Abstract available

  214. TATAR O, Bastien G, Abdel-Baki A, Huynh C, et al
    A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis.
    Psychiatry Res. 2020;288:112940.
    PubMed     Abstract available

  215. DEAN B, Scarr E
    Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia.
    Psychiatry Res. 2020;288:112989.
    PubMed     Abstract available

  216. WANG KZ, Bani-Fatemi A, Adanty C, Harripaul R, et al
    Prediction of physical violence in schizophrenia with machine learning algorithms.
    Psychiatry Res. 2020;289:112960.
    PubMed     Abstract available

  217. BARADITS M, Bitter I, Czobor P
    Multivariate patterns of EEG microstate parameters and their role in the discrimination of patients with schizophrenia from healthy controls.
    Psychiatry Res. 2020;288:112938.
    PubMed     Abstract available

  218. ZANDIFAR A, Badrfam R
    COVID-19: Considering the prevalence of schizophrenia in the coming decades.
    Psychiatry Res. 2020;288:112982.

  219. DEL CACHO N, Vila-Badia R, Butjosa A, Cuadras D, et al
    Sexual dysfunction in drug- naive first episode nonaffective psychosis patients. Relationship with prolactin and psychotic symptoms. Gender differences.
    Psychiatry Res. 2020;289:112985.
    PubMed     Abstract available

    February 2020
  220. BAUER CCC, Okano K, Ghosh SS, Lee YJ, et al
    Real-time fMRI neurofeedback reduces auditory hallucinations and modulates resting state connectivity of involved brain regions: Part 2: Default mode network -preliminary evidence.
    Psychiatry Res. 2020;284:112770.
    PubMed     Abstract available

  221. DICKERSON F, Gennusa JV 3rd, Stallings C, Origoni A, et al
    Protein intake is associated with cognitive functioning in individuals with psychiatric disorders.
    Psychiatry Res. 2020;284:112700.
    PubMed     Abstract available

  222. ROSSELL SL, Labuschagne I, Castle DJ, Toh WL, et al
    Delusional themes in Body Dysmorphic Disorder (BDD): Comparisons with psychotic disorders and non-clinical Controls.
    Psychiatry Res. 2020;284:112694.
    PubMed     Abstract available

  223. DODELL-FEDER D, Shovestul B, Woodyatt J, Popov V, et al
    Social anhedonia, social networks, and psychotic-like experiences: A test of social deafferentation.
    Psychiatry Res. 2020;284:112682.
    PubMed     Abstract available

    September 2019
  224. ALLSOPP K, Read J, Corcoran R, Kinderman P, et al
    Heterogeneity in psychiatric diagnostic classification.
    Psychiatry Res. 2019;279:15-22.
    PubMed     Abstract available

    August 2019
  225. DE BOER JN, Vingerhoets C, Hirdes M, McAlonan GM, et al
    Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis.
    Psychiatry Res. 2019;278:294-302.
    PubMed     Abstract available

  226. KUO SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, et al
    Establishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT).
    Psychiatry Res. 2019;278:116-124.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.